Related Experiment Video
Updated: Mar 14, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Effect of New-Onset Left Bundle Branch Block After Transcatheter Aortic Valve Implantation (CoreValve) on Mortality,
José López-Aguilera1, José M Segura Saint-Gerons1, Francisco Mazuelos Bellido1
1Reina Sofia University Hospital, Maimonides Institute for Biomedical Research, University of Cordoba, Córdoba, Spain.
Insights
New left bundle branch block (LBBB) after transcatheter aortic valve implantation (TAVI) does not increase long-term mortality or heart failure hospitalizations. This study found no significant difference in pacemaker needs between patients with and without new-onset LBBB post-TAVI.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Electrophysiology
Background:
- New-onset conduction disturbances, particularly left bundle branch block (LBBB), are frequent after transcatheter aortic valve implantation (TAVI).
- The clinical significance of new-onset LBBB following TAVI regarding long-term outcomes remains debated.
Purpose of the Study:
- To investigate the long-term clinical impact of new-onset LBBB after TAVI.
- To assess the association between new-onset LBBB and mortality, heart failure hospitalizations, and pacemaker implantation rates.
Main Methods:
- A cohort of 153 patients undergoing CoreValve implantation for severe aortic stenosis was analyzed.
- Patients were divided into two groups: persistent new-onset LBBB (n=80) and no conduction disturbances (n=73).
- Follow-up included assessments at 1 month, 6 months, 12 months, and annually thereafter, with a mean follow-up of 32 months.
Main Results:
- Persistent new-onset LBBB was observed in 36% of patients immediately post-TAVI.
- No significant differences were found in long-term mortality (39% vs 48%) or re-hospitalizations for heart failure (11% vs 16%) between groups.
- The incidence of late pacemaker implantation was similar in both groups (10% vs 13%).
Conclusions:
- New-onset LBBB after CoreValve TAVI is not associated with an increased risk of late pacemaker implantation.
- The study suggests that new-onset LBBB following TAVI does not adversely affect long-term mortality or heart failure re-hospitalization rates.
Abstract:
New-onset conduction disturbances are common after transcatheter aortic valve implantation (TAVI). The most common complication is left bundle branch block (LBBB). The clinical impact of new-onset LBBB after TAVI remains controversial. The aim of this study was to analyze the clinical impact of new-onset LBBB in terms of mortality and morbidity (need for pacemakers and admissions for heart failure) at long-term follow-up. From April 2008 to December 2014, 220 patients who had severe aortic stenosis were treated with the implantation of a CoreValve prosthesis. Sixty-seven of these patients were excluded from the analysis, including 22 patients with pre-existing LBBB and 45 with a permanent pacemaker, implanted previously or within 72 hours of implantation. The remaining 153 patients were divided into 2 groups: group 1 (n = 80), those with persistent new-onset LBBB, and group 2 (n = 73), those without conduction disturbances after treatment. Both groups were followed up at 1 month, 6 months, 12 months, and yearly thereafter. Persistent new-onset LBBB occurred in 80 patients (36%) immediately after TAVI; 73 patients (33%) did not develop conduction disturbances. The mean follow-up time of both groups was 32 ± 22 months (range 3 to 82 months), and there were no differences in time between the groups. There were no differences in mortality between the groups (39% vs 48%, p = 0.58). No differences were observed between the groups in re-hospitalizations for heart failure (11% vs 16%, p = 0.55). Group 1 did not require pacemaker implantation more often at follow-up (10% vs 13%, p = 0.38) than group 2. In conclusion, new-onset LBBB was not associated with a higher incidence of late need for a permanent pacemaker after CoreValve implantation. In addition, it was not associated with a higher risk of late mortality or re-hospitalization.
More Related Videos
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Aortic Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Mitral Stenosis IV: Nursing Management
Cardiac Catheterization IV: Nursing Management

